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Abstract: H. influenzae is a fastidious
bacteria, so the selection of a reliable method
for in-vitro susceptibility tests is particularly
important. The E-test is a practical method
for
detecting
in-vitro
antimicrobial
susceptibility of antibiotics by MIC values. This
study was performed using the E-test for
direct patient management and in order to
obtain epidemiological data on H. influenzae.
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The detection of antimicrobial agent
resistance among fifty-seven H. influenzae
isolates from lower respiratory tract
infections in childhood was studied by the Etest. The E-test was performed on HTM agar
according to the instruction manual

Introduction
Following reports of β-lactamase-producing H.
influenzae in 1974, the need for a standardized method
for antimicrobial susceptibility testing of H. influenzae
became apparent (1). The E-test is a new product for
quantitative antimicrobial susceptibility testing. It is a
practical method like the disk diffusion method (2).
It is well known that antimicrobial susceptibility tests
must be performed for direct patient management as well
as to obtain epidemiological data especially when detailed
results from microbiological tests are not available (3).
The aim of the present study was to obtain data on
the susceptibility pattern of H. influenzae to some
antibiotics by means of the E-test.

Material and Methods
Fifty-seven Haemophilus influenzae strains were used
in this study. After visual examination of the predominant
cell types, acceptable sputum specimens were used as the
samples. Some of the strains were isolated twice from

recommendations. The susceptibility ratios
and the MIC90 values of the isolates for
ampicillin,
cefaclor,
cefotaxime,
chloramphenicol, ciprofloxacin and imipenem
were 89 % and 1.5µg/ml, 98.2 % and
6µg/ml, 100 % and 0.047µg/ml, 98.2 % and
1.5µg/ml, 100 % and 0.075µg/ml, and
100% and 1.0µg/ml respectively. All of the
antibiotics tested were found to be effective
against H. influenzae.
Key Words: Haemophilus influenzae,
microbial drug resistance, E-test, respiratory
tract infections

three paitents and three times from one patient at
different times, but the serotyping and biotyping results
were different. All of the strains were isolated in 1996
and Haemophilus influenzae ATCC 49247 was used as
the control strain.
The strains used in this study were isolated from
patients with acute exacerbation of lower respiratory
tract infections, and most of them had cystic fibrosis. The
ages of the patients ranged from 4 months to 17 years
and the median age was 7.3.
The E-tests for Haemophilus influenzae were
performed on Haemophilus test medium (HTM) agar
(Oxoid, UK). For inoculum preparation, overnight
cultures were inoculated on chocolate agar and incubated
at 35ºC in the presence of 5-10% CO2 . The inoculum
was prepared by direct suspension of the colonies. A
bacterial suspension with a turbidity equivalent to that of
the McFarland 0.5 standard was prepared in MuellerHinton broth supplemented with 15µg/ml bovine
hematine (Sigma, IL), 15µg/ml NAD (Sigma, IL) and yeast
extract (Difco, IL). The 150-mm diameter agar plates
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strains were susceptible to cefotaxime (MIC90 0.047
µg/ml) and imipenem (MIC90 1.0 µg/ml), and 98.2% of
the strains were susceptible to cefaclor (MIC90 6 µg/ml)
and chloramphenicol (MIC90 1.5 µg/ml). The
susceptibility rate of the strains to ciprofloxacin was 94.7
% (MIC90 0.75 µg/ml), and all of these antibiotics were
found to be effective against H. influenzae. The lowest
susceptibility rate was that of ampicillin, with 89 %
(MIC90 1.5 µg/ml), but it was still found to be effective.
Data from the literature on the susceptibilty patterns of
H. influenzae strains are reviewed in Table 2.

were inoculated by confluent swabbing of the surface
with the adjusted inoculum suspensions. The E-test strips
(AB Biodisk, Sweden) were placed in an equidistant radial
fashion on the surface of the plates. The incubation was
conducted at 35ºC in 5% CO2 for 16-18 hours. E-test
MIC evaluations were interpreted by noting the point of
intersection of the growth ellipse margin with the MIC
scale on the E-test strip when viewed from the upper
agar surface with the plate lids removed. The antibiotics
used were ciprofloxacin, ampicillin, chloramphenicol,
cefotaxime, cefaclor and imipenem and the breakpoints
used for interpretation were 1µg/ml, 1µg/ml, 2µg/ml,
2µg/ml, 8µg/ml, and 4µg/ml respectively. The results
were evaluated according to NCCLS and the E-test
instruction manual recommendations (4).

Table 1.

Results
The in-vitro MIC results and susceptibility rates of 57
H. influenzae strains are shown in Table 1. All of the

Table 2.

MIC results and susceptibility percentages of Haemophilus
influenzae strains tested (n=57).
MIC50

MIC90

Range

Susceptibility (%)

Ciprofloxacin
0.023
Ampicillin
0.38
Chloramphenicol 0.50
Cefotaxime
0.016
Cefaclor
2
Imipenem
0.50

0.75
1.5
1.5
0.047
6
1.0

0.008-4
0.064-6
0.064-3
0.016-2
0.38-12
0.002-4

94.7
89
98.2
100
98.2
100

Data of other investigations of susceptibility rate and MIC50/90 values.
Ampicillin

Reference list by authors
country and test method

S. (%)

Doern G V, USA (5)
Gür D, Turkey (6) E-test

MIC50/90
mg/ml

Ciprofloxacin
S. (%)

MIC50/90
mg/ml

Chloramphenicol
S. (%)

0.25/1/
64/256*
92

MIC50/90
mg/ml

Cefotaxime
S. (%)

MIC50/90
mg/ml

Cefaclor
S. (%)

0.5/1/
0.5/1*
100

100

85.4

96.4

97.1

89

96

96

90

93

97

Aytu¤ fi, Turkey (9)

1/6

Dornbush K,
Sweden(13) E-test

0.032/0.
047

Hasegawa M,
Japan (14) E-test

0.125/0.
75

-/1/1/64*

Jones RN, USA (15)
Broth-microdilution

-/2/-/2*

0.25/8
83.2

0.25/64

4/32
97.9

0.25/0.25

100

0.01/0.01

Jones RN, USA (17)

-/8

Yeo SF, UK (18)
Disk diffusion

4/8

Thege MK, Hungary (19)

88

Hryniewics W, Poland (20)

80

*β-lactamase (-)/(+)
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S. (%)

100

Özalp M, Turkey (8)
Disk diffusion

Moloney AC, Ireland (16)
Broth-microdilution

MIC50/90
mg/ml
4/16/
4/32*

fiener B, Turkey (7)

Sidorenco S V,
USA (12) E-test

Imipenem

98.7

94.7
73

MIC50/90
mg/ml

N. ÇÖPLÜ, O.C. AKTEPE, S. ULUUTKU, E. GÜVENER

Discussion
Laboratory testing of the in-vitro activity of
antimicrobial agents is of use when deciding upon a
therapeutic regimen, and can also provide important
epidemiological data to assist the selection of empiric
therapy. This study revealed the susceptibility pattern of
H.
influenzae
for
ciprofloxacin,
ampicillin,
chloramphenicol, cefotaxime, cefaclor and imipenem. All
of the antimicrobials tested were found to be effective
against H. influenzae. Ampicillin exhibited the lowest
susceptibility rate (89%). Ampicillin resistance may be
mediated by TEM-1 type or ROB-1 type β-lactamase
enzyme as well as alterations both in the penicillin-binding
proteins and in the cell wall, resulting in reduced
permeability of the cell membrane to antimicrobial
agents, including β-Lactamase-negative but ampicillinresistant (BLNAR) strains (5). This relatively low
susceptibility rate may be due to the frequent use of
ampicillin in Turkey. Ampicillin-resistant strains show
diminished susceptibility to some cephalosporins, and
cefaclor is one of these. This is because of the β-lactamase
enzyme, and the fact that cefaclor is a β-lactam antibiotic.
In the present study, the cefaclor susceptibility rate was
98.2%, and there was no correlation between the
ampicillin-resistant and cefaclor-resistant strains when a
direct comparison of susceptibility to the two antibiotics
was carried out. The chloramphenicol susceptibility rate
was 98.2%. Thus, both cefaclor and chloramphenicol
appear to be suitable for empiric therapy. The
ciprofloxacine susceptibility rate was also highly favorable
(94.7%). Cefotaxime and imipenem, with a susceptibility
rate of 100%, exhibited the highest effectiveness.
We searched the literature for other investigations of
H. influenzae susceptibility patterns carried out during
the years 1990-1998, in the U.S.A., Europe and Japan,
as well as Turkey. The data from these investigations are
shown in Table 2. Our results are similar to those
obtained in these previous studies. However, when the
MIC 50/90 values are evaluated, in some studies βlactamase positive and β-lactamase negative strains were
separated and the β-lactamase positive strains produced
higher MIC values for ampicillin, cefaclor and imipenem

than in our study (Table 2). In our study, we did not
separate the strains into β-lactamase positive or negative,
and as for the BLNAR strains, we wanted to obtain a total
result. It is, therefore, not surprising that the MIC values
in β-lactamase-positive groups were higher than our
overall MIC values.
In those Turkish studies which investigated ampicillin,
cefaclor and cefotaxime, both the susceptibility patterns
and MIC50/90 values were within the range of results
obtained in our study (6-9).
The standardization of methods of antimicrobial
susceptibility testing for H. influenzae has been hampered
by the fastidious growth of the bacterium. Thus, it is
important to assess the ability of in-vitro systems in order
to enable the detection of antimicrobial agent resistance
in H. influenzae isolates (1). The E-test represents a new
and innovative approach in the determination of
antimicrobial susceptibility which is potentially applicable
to a wide array of drugs and microorganisms (10). The
E-test may be well suited to the testing of certain
fastidious bacteria like H. influenzae. In a study carried ou
in the U.S.A., 4 in-vitro susceptibility test techniques were
assessed (11). These were: Vitek, the E-test, microscan
and micromedia. In terms of ampicillin susceptibility, the
rate varied from 83 to 100%. The E test result was
100%. For chloramphenicol and cefotaxime all of the
tests exhibited a 100% susceptibility rate. For cefaclor,
the susceptibility rates varied from 83 to 95%, and the
E-test result was 95%. Some of the studies we evaluated
used the E-test (3,6,11-14), while the others used agar
dilution, disk diffusion and broth microdilution
(8,9,11,15-18). The E-test results correlated well with
those obtained by the other methods.
In conclusion, the E-test has a potential for use for H.
influenzae and the tested antimicrobials are effective. All
of the agents tested, with the exception of ampicillin, can
be used in the empirical treatment of infections suspected
to be due to H. influenzae. However, in-vitro
susceptibility tests are required for the identification of
the susceptibility patterns of individual isolate since
resistance is still likely.
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